Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma. Badodi S, Pomella N, Lim YM, Brandner S, et al. Neuro Oncol 2022 Feb 25. pii: 6537125. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Badodi S, Pomella N, Lim YM, Brandner S, et al. Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma. Neuro Oncol 2022 Feb 25. pii: 6537125. doi: 10.1093.
PMID: 35213723